Takashi Akamizu

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 13

Top Topics

Machine Learning

Metastatic Renal Cell Carcinoma

Magnetic Resonance Imaging

Top Venues

Endocrine journal

Pathology international

JCEM case reports

This page only lists publications with an associated author ORCID identifier.

Publications

Risa Kanematsu, Mitsuyoshi Hirokawa, Ayana Suzuki, Miyoko Higuchi, Akira Miyauchi, Takashi Akamizu
Diagnostic significance of clay-like materials aspirated from thyroid nodules. CytoJournal 21 (2024)
Hanna Deguchi-Horiuchi, Mitsuru Ito, Sawako Takahashi, Kazuyoshi Kousaka, Mako Hisakado, Shuji Fukata, Takumi Kudo, Eijun Nishihara, Mitsushige Nishikawa, Akira Miyauchi, Takashi Akamizu
Comparison of pathophysiology in subclinical hyperthyroidism with different etiologies. Endocrine journal (2024)
Yasushi Furukawa, Keiko Tanaka, Osamu Isozaki, Atsushi Suzuki, Tadao Iburi, Kumiko Tsuboi, Moritake Iguchi, Naotetsu Kanamoto, Kanshi Minamitani, Shu Wakino, Tetsurou Satoh, Satoshi Teramukai, Eizen Kimura, Yoshihiro Miyake, Takashi Akamizu
Prospective Multicenter Registry-Based Study on Thyroid Storm: The Guidelines for the Management from Japan are Useful. The Journal of clinical endocrinology and metabolism (2024)
Hanna Deguchi-Horiuchi, Mitsuru Ito, Sawako Takahashi, Kazuyoshi Kousaka, Mako Hisakado, Shuji Fukata, Takumi Kudo, Eijun Nishihara, Mitsushige Nishikawa, Akira Miyauchi, Takashi Akamizu
Comparison of pathophysiology in subclinical hyperthyroidism with different etiologies. Endocrine journal 71 (4) (2024)
Risa Kanematsu, Mitsuyoshi Hirokawa, Ayana Suzuki, Miyoko Higuchi, Akira Miyauchi, Takashi Akamizu
Diagnostic significance of clay-like materials aspirated from thyroid nodules. CytoJournal 21 (2024)
Sawako Takahashi, Eijun Nishihara, Shuji Fukata, Akira Miyauchi, Takashi Akamizu
Familial Nonautoimmune Hyperthyroidism Due to a TSH Receptor Gene Pathogenic Variant. JCEM case reports 2 (10) (2024)
Hanna Deguchi-Horiuchi, Mitsuru Ito, Sawako Takahashi, Kazuyoshi Kousaka, Mako Hisakado, Shuji Fukata, Takumi Kudo, Eijun Nishihara, Mitsushige Nishikawa, Akira Miyauchi, Takashi Akamizu
Comparison of pathophysiology in subclinical hyperthyroidism with different etiologies. Endocrine journal 71 (4) (2024)
Naoki Yamao, Mitsuyoshi Hirokawa, Ayana Suzuki, Miyoko Higuchi, Tomo Ishisaka, Akira Miyauchi, Takashi Akamizu
High-grade medullary thyroid carcinoma with papillary-like nuclear features: A report of five cases. Diagnostic cytopathology (2023)
Mitsuyoshi Hirokawa, Michiko Matsuse, Norisato Mitsutake, Ayana Suzuki, Miyoko Higuchi, Toshitetsu Hayashi, Hiroshi Kamma, Akira Miyauchi, Takashi Akamizu
Non-hyalinizing trabecular thyroid adenoma: a novel thyroid tumor with diagnostic pitfalls of hyalinizing trabecular adenoma and medullary thyroid carcinoma. Diagnostic pathology 18 (1) (2023)
Aki Tanaka, Mitsuyoshi Hirokawa, Ayana Suzuki, Miyoko Higuchi, Akira Miyauchi, Takashi Akamizu
Clinical, cytological, and pathological characteristics of metastatic renal cell carcinoma to the thyroid: A study of 14 cases at a Japanese single institution. Pathology international (2023)
Mitsuyoshi Hirokawa, Masahiro Ito, Noriko Motoi, Tomohiro Chiba, Yoshiaki Imamura, Hironao Yasuoka, Rumi Hino, Miyoko Higuchi, Akira Miyauchi, Takashi Akamizu
Prevalence and diagnostic significance of non-invasive follicular thyroid neoplasm with papillary-like nuclear features in Japan-A multi-institutional study. Pathology international (2023)
Mitsuyoshi Hirokawa, Hirohiko Niioka, Ayana Suzuki, Masatoshi Abe, Yusuke Arai, Hajime Nagahara, Akira Miyauchi, Takashi Akamizu
Application of deep learning as an ancillary diagnostic tool for thyroid FNA cytology. Cancer cytopathology (2022)
Min Hu, Chikashi Asami, Hiroshi Iwakura, Yasuyo Nakajima, Ryousuke Sema, Tsuyoshi Kikuchi, Tsuyoshi Miyata, Koji Sakamaki, Takumi Kudo, Masanobu Yamada, Takashi Akamizu, Yasubumi Sakakibara
Development and preliminary validation of a machine learning system for thyroid dysfunction diagnosis based on routine laboratory tests. Communications medicine 2 (2022)